Kingstone Companies heads into its May 7 Q1 earnings call with short sellers in full retreat — and options traders swinging hard to the bullish side.
The short covering story is the week's headline. SI % FF dropped from around 4.1% to 2.9% between April 23 and April 24 — a roughly 30% single-session collapse in estimated short positions. That move has held, leaving short interest at a six-week low of 2.9% of free float as of April 28, down from a peak near 4.8% in early April. The covering was orderly rather than forced: availability is loose, cost to borrow sits at just 0.81%, and the ORTEX short score has dropped from the low 40s to 35, now well into the lower half of the universe. Short sellers appear to have taken profits into the stock's one-month rally of nearly 20% rather than being squeezed out.
Options positioning confirms the shift in mood. The put/call ratio has collapsed to 0.025 — nearly 1.4 standard deviations below its 20-day average of 0.088, and close to the lowest level of the past year. Three weeks ago, the PCR was running near 0.13, a clear hedging posture heading into tariff volatility. That defensive cover has been stripped away. What remains is an options market almost entirely oriented toward calls, with puts at a 12-month floor relative to open interest.
The Street picture for KINS is limited. The most recent analyst coverage on record — a Janney Montgomery Scott Buy initiation with a $6.50 target — dates to July 2024 and is materially stale given the stock now trades at $16.95. Earlier Piper Sandler actions stretch back to 2023 and earlier, with targets that bear no relation to current price levels. None of this data should be read as current consensus. What is current: an EPS surprise factor score in the 95th percentile, meaning Kingstone has a strong recent track record of beating estimates. That detail matters with earnings a week away. The dividend, last paid in mid-2022, has been suspended and is not a live consideration.
Institutional flow adds quiet ballast. Royce & Associates reported a full new position of roughly 449,000 shares as of March 31 — one of the cleaner institutional conviction signals in the holder list. Vanguard and BlackRock both added modestly in Q1. On the insider side, the picture is mixed but not alarming. An independent director sold 13,500 shares at $18 on April 16, and the CFO made a small sale in early March. The CEO, Meryl Golden, sold 7,735 shares at $16.83 in January. However, the prior cluster from May 2025 — when both the Chairman and the CEO bought stock around $16 — provides a constructive backdrop for the current price level.
Past earnings reactions at Kingstone have been asymmetric. The last print in March produced a 3.4% gain on day one before reversing to a 3.8% loss over the following week. The print before that moved the stock down 5.3% on day one and 6.3% over five days. The average one-day move across four recent events is roughly 1.7%, but with a clear skew toward weakness on the multi-day follow-through. With the stock up 19% over the past month heading into the May 7 report, the positioning question is whether the short-covering rally has already pulled forward much of the optimism — or whether the EPS surprise track record can extend the move.
The week's main event is the May 7 earnings release, where the combination of near-record call-skew in options, fresh institutional buying, and a historically strong beat rate sets up an unusually clean read on whether the recent price strength is fundamentally supported.
See the live data behind this article on ORTEX.
Open KINS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
